Search

Your search keyword '"Novosiadly, Ruslan D."' showing total 33 results
Start Over Author "Novosiadly, Ruslan D."
33 results on '"Novosiadly, Ruslan D."'

1. Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer

Author

Hakenberg, Oliver W., Perez-Gracia, Jose Luis, Castellano, Daniel, Demkow, Tomasz, Ali, Tarek, Caffo, Orazio, Heidenreich, Axel, Schultze-Seemann, Wolfgang, Sautois, Brieuc, Pavlik, Ivan, Qin, Amy, Novosiadly, Ruslan D., Shahir, Ashwin, Ilaria, Robert, Jr., and Nippgen, Johannes

Published
2019
Full Text
View/download PDF

2. The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade

Author

Schaer, David A., Beckmann, Richard P., Dempsey, Jack A., Huber, Lysiane, Forest, Amelie, Amaladas, Nelusha, Li, Yanxia, Wang, Ying Cindy, Rasmussen, Erik R., Chin, Darin, Capen, Andrew, Carpenito, Carmine, Staschke, Kirk A., Chung, Linda A., Litchfield, Lacey M., Merzoug, Farhana F., Gong, Xueqian, Iversen, Philip W., Buchanan, Sean, de Dios, Alfonso, Novosiadly, Ruslan D., and Kalos, Michael

Published
2018
Full Text
View/download PDF

3. Supplementary Data File from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity

Author

Kotanides, Helen, primary, Li, Yiwen, primary, Malabunga, Maria, primary, Carpenito, Carmine, primary, Eastman, Scott W., primary, Shen, Yang, primary, Wang, George, primary, Inigo, Ivan, primary, Surguladze, David, primary, Pennello, Anthony L., primary, Persaud, Krishnadatt, primary, Hindi, Sagit, primary, Topper, Michael, primary, Chen, Xinlei, primary, Zhang, Yiwei, primary, Bulaon, Danielle K., primary, Bailey, Tim, primary, Lao, Yanbin, primary, Han, Bing, primary, Torgerson, Stacy, primary, Chin, Darin, primary, Sonyi, Andreas, primary, Haidar, Jaafar N., primary, Novosiadly, Ruslan D., primary, Moxham, Christopher M., primary, Plowman, Gregory D., primary, Ludwig, Dale L., primary, and Kalos, Michael, primary

Published
2023
Full Text
View/download PDF

4. Data from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity

Author

Kotanides, Helen, primary, Li, Yiwen, primary, Malabunga, Maria, primary, Carpenito, Carmine, primary, Eastman, Scott W., primary, Shen, Yang, primary, Wang, George, primary, Inigo, Ivan, primary, Surguladze, David, primary, Pennello, Anthony L., primary, Persaud, Krishnadatt, primary, Hindi, Sagit, primary, Topper, Michael, primary, Chen, Xinlei, primary, Zhang, Yiwei, primary, Bulaon, Danielle K., primary, Bailey, Tim, primary, Lao, Yanbin, primary, Han, Bing, primary, Torgerson, Stacy, primary, Chin, Darin, primary, Sonyi, Andreas, primary, Haidar, Jaafar N., primary, Novosiadly, Ruslan D., primary, Moxham, Christopher M., primary, Plowman, Gregory D., primary, Ludwig, Dale L., primary, and Kalos, Michael, primary

Published
2023
Full Text
View/download PDF

5. Data from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

Author

Kotanides, Helen, primary, Sattler, Rose Marie, primary, Lebron, Maria B., primary, Carpenito, Carmine, primary, Shen, Juqun, primary, Li, Jingxing, primary, Surguladze, David, primary, Haidar, Jaafar N., primary, Burns, Colleen, primary, Shen, Leyi, primary, Inigo, Ivan, primary, Pennello, Anthony L., primary, Forest, Amelie, primary, Chen, Xinlei, primary, Chin, Darin, primary, Sonyi, Andreas, primary, Topper, Michael, primary, Boucher, Lauren, primary, Sharma, Prachi, primary, Zhang, Yiwei, primary, Burtrum, Douglas, primary, Novosiadly, Ruslan D., primary, Ludwig, Dale L., primary, Plowman, Gregory D., primary, and Kalos, Michael, primary

Published
2023
Full Text
View/download PDF

6. Figure S9 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

Author

Kotanides, Helen, primary, Sattler, Rose Marie, primary, Lebron, Maria B., primary, Carpenito, Carmine, primary, Shen, Juqun, primary, Li, Jingxing, primary, Surguladze, David, primary, Haidar, Jaafar N., primary, Burns, Colleen, primary, Shen, Leyi, primary, Inigo, Ivan, primary, Pennello, Anthony L., primary, Forest, Amelie, primary, Chen, Xinlei, primary, Chin, Darin, primary, Sonyi, Andreas, primary, Topper, Michael, primary, Boucher, Lauren, primary, Sharma, Prachi, primary, Zhang, Yiwei, primary, Burtrum, Douglas, primary, Novosiadly, Ruslan D., primary, Ludwig, Dale L., primary, Plowman, Gregory D., primary, and Kalos, Michael, primary

Published
2023
Full Text
View/download PDF

7. Table S1 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

Author

Kotanides, Helen, primary, Sattler, Rose Marie, primary, Lebron, Maria B., primary, Carpenito, Carmine, primary, Shen, Juqun, primary, Li, Jingxing, primary, Surguladze, David, primary, Haidar, Jaafar N., primary, Burns, Colleen, primary, Shen, Leyi, primary, Inigo, Ivan, primary, Pennello, Anthony L., primary, Forest, Amelie, primary, Chen, Xinlei, primary, Chin, Darin, primary, Sonyi, Andreas, primary, Topper, Michael, primary, Boucher, Lauren, primary, Sharma, Prachi, primary, Zhang, Yiwei, primary, Burtrum, Douglas, primary, Novosiadly, Ruslan D., primary, Ludwig, Dale L., primary, Plowman, Gregory D., primary, and Kalos, Michael, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Tables S1-S4 and Supplementary Figures S1-S6 from Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance

Author

Bagchi, Atrish, primary, Haidar, Jaafar N., primary, Eastman, Scott W., primary, Vieth, Michal, primary, Topper, Michael, primary, Iacolina, Michelle D., primary, Walker, Jason M., primary, Forest, Amelie, primary, Shen, Yang, primary, Novosiadly, Ruslan D., primary, and Ferguson, Kathryn M., primary

Published
2023
Full Text
View/download PDF

9. Supplementary Materials and Methods from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

Author

Kotanides, Helen, primary, Sattler, Rose Marie, primary, Lebron, Maria B., primary, Carpenito, Carmine, primary, Shen, Juqun, primary, Li, Jingxing, primary, Surguladze, David, primary, Haidar, Jaafar N., primary, Burns, Colleen, primary, Shen, Leyi, primary, Inigo, Ivan, primary, Pennello, Anthony L., primary, Forest, Amelie, primary, Chen, Xinlei, primary, Chin, Darin, primary, Sonyi, Andreas, primary, Topper, Michael, primary, Boucher, Lauren, primary, Sharma, Prachi, primary, Zhang, Yiwei, primary, Burtrum, Douglas, primary, Novosiadly, Ruslan D., primary, Ludwig, Dale L., primary, Plowman, Gregory D., primary, and Kalos, Michael, primary

Published
2023
Full Text
View/download PDF

11. Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients

Author

Bray, Steven M., Lee, Jeeyun, Kim, Seung Tae, Hur, Joon Young, Ebert, Philip J., Calley, John N., Wulur, Isabella H., Gopalappa, Thejaswini, Wong, Swee Seong, Qian, Hui-Rong, Ting, Jason C., Liu, Jiangang, Willard, Melinda D., Novosiadly, Ruslan D., Park, Young Suk, Park, Joon Oh, Lim, Ho Yeong, Kang, Won Ki, Aggarwal, Amit, Kim, Hee Cheol, and Reinhard, Christoph

Published
2019
Full Text
View/download PDF

12. Supplementary Materials & Methods from The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy

Author

Schaer, David A., primary, Geeganage, Sandaruwan, primary, Amaladas, Nelusha, primary, Lu, Zhao Hai, primary, Rasmussen, Erik R., primary, Sonyi, Andreas, primary, Chin, Darin, primary, Capen, Andrew, primary, Li, Yanxia, primary, Meyer, Catalina M., primary, Jones, Bonita D., primary, Huang, Xiaodong, primary, Luo, Shuang, primary, Carpenito, Carmine, primary, Roth, Kenneth D., primary, Nikolayev, Alexander, primary, Tan, Bo, primary, Brahmachary, Manisha, primary, Chodavarapu, Krishna, primary, Dorsey, Frank C., primary, Manro, Jason R., primary, Doman, Thompson N., primary, Donoho, Gregory P., primary, Surguladze, David, primary, Hall, Gerald E., primary, Kalos, Michael, primary, and Novosiadly, Ruslan D., primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figures from Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations

Author

Yao, Yung-mae M., primary, Donoho, Gregory P., primary, Iversen, Philip W., primary, Zhang, Youyan, primary, Van Horn, Robert D., primary, Forest, Amelie, primary, Novosiadly, Ruslan D., primary, Webster, Yue Wang, primary, Ebert, Philip, primary, Bray, Steven, primary, Ting, Jason C., primary, Aggarwal, Amit, primary, Henry, James R., primary, Tiu, Ramon V., primary, Plowman, Gregory D., primary, and Peng, Sheng-Bin, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure Legends & Tables from The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy

Author

Schaer, David A., primary, Geeganage, Sandaruwan, primary, Amaladas, Nelusha, primary, Lu, Zhao Hai, primary, Rasmussen, Erik R., primary, Sonyi, Andreas, primary, Chin, Darin, primary, Capen, Andrew, primary, Li, Yanxia, primary, Meyer, Catalina M., primary, Jones, Bonita D., primary, Huang, Xiaodong, primary, Luo, Shuang, primary, Carpenito, Carmine, primary, Roth, Kenneth D., primary, Nikolayev, Alexander, primary, Tan, Bo, primary, Brahmachary, Manisha, primary, Chodavarapu, Krishna, primary, Dorsey, Frank C., primary, Manro, Jason R., primary, Doman, Thompson N., primary, Donoho, Gregory P., primary, Surguladze, David, primary, Hall, Gerald E., primary, Kalos, Michael, primary, and Novosiadly, Ruslan D., primary

Published
2023
Full Text
View/download PDF

15. Supplementary Data from The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy

Author

Schaer, David A., primary, Geeganage, Sandaruwan, primary, Amaladas, Nelusha, primary, Lu, Zhao Hai, primary, Rasmussen, Erik R., primary, Sonyi, Andreas, primary, Chin, Darin, primary, Capen, Andrew, primary, Li, Yanxia, primary, Meyer, Catalina M., primary, Jones, Bonita D., primary, Huang, Xiaodong, primary, Luo, Shuang, primary, Carpenito, Carmine, primary, Roth, Kenneth D., primary, Nikolayev, Alexander, primary, Tan, Bo, primary, Brahmachary, Manisha, primary, Chodavarapu, Krishna, primary, Dorsey, Frank C., primary, Manro, Jason R., primary, Doman, Thompson N., primary, Donoho, Gregory P., primary, Surguladze, David, primary, Hall, Gerald E., primary, Kalos, Michael, primary, and Novosiadly, Ruslan D., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Tables from Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations

Author

Yao, Yung-mae M., primary, Donoho, Gregory P., primary, Iversen, Philip W., primary, Zhang, Youyan, primary, Van Horn, Robert D., primary, Forest, Amelie, primary, Novosiadly, Ruslan D., primary, Webster, Yue Wang, primary, Ebert, Philip, primary, Bray, Steven, primary, Ting, Jason C., primary, Aggarwal, Amit, primary, Henry, James R., primary, Tiu, Ramon V., primary, Plowman, Gregory D., primary, and Peng, Sheng-Bin, primary

Published
2023
Full Text
View/download PDF

17. Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade

Author

Holmgaard, Rikke B., Schaer, David A., Li, Yanxia, Castaneda, Stephen P., Murphy, Mary Y., Xu, Xiaohong, Inigo, Ivan, Dobkin, Julie, Manro, Jason R., Iversen, Philip W., Surguladze, David, Hall, Gerald E., Novosiadly, Ruslan D., Benhadji, Karim A., Plowman, Gregory D., Kalos, Michael, and Driscoll, Kyla E.

Published
2018
Full Text
View/download PDF

18. Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054

Author

Li, Yiwen, Carpenito, Carmine, Wang, George, Surguladze, David, Forest, Amelie, Malabunga, Maria, Murphy, Mary, Zhang, Yiwei, Sonyi, Andreas, Chin, Darin, Burtrum, Douglas, Inigo, Ivan, Pennello, Anthony, Shen, Leyi, Malherbe, Laurent, Chen, Xinlei, Hall, Gerald, Haidar, Jaafar N., Ludwig, Dale L., Novosiadly, Ruslan D., and Kalos, Michael

Published
2018
Full Text
View/download PDF

20. An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer

Author

Novello, Silvia, Scagliotti, Giorgio, de Castro, Gilberto, Jr., Kiyik, Murat, Kowalyszyn, Rubén, Deppermann, Karl-Matthias, Arriola, Edurne, Bosquee, Lionel, Novosiadly, Ruslan D., Nguyen, Tuan S., Forest, Amelie, Tang, Shande, Kambhampati, Siva Rama Prasad, Cosaert, Jan, and Reck, Martin

Published
2017
Full Text
View/download PDF

21. SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery

Author

Hu-Lieskovan, Siwen, primary, Bhaumik, Srabani, additional, Dhodapkar, Kavita, additional, Grivel, Jean-Charles J B, additional, Gupta, Sumati, additional, Hanks, Brent A, additional, Janetzki, Sylvia, additional, Kleen, Thomas O, additional, Koguchi, Yoshinobu, additional, Lund, Amanda W, additional, Maccalli, Cristina, additional, Mahnke, Yolanda D, additional, Novosiadly, Ruslan D, additional, Selvan, Senthamil R, additional, Sims, Tasha, additional, Zhao, Yingdong, additional, and Maecker, Holden T, additional

Published
2020
Full Text
View/download PDF

22. Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity

Author

Kotanides, Helen, primary, Li, Yiwen, additional, Malabunga, Maria, additional, Carpenito, Carmine, additional, Eastman, Scott W., additional, Shen, Yang, additional, Wang, George, additional, Inigo, Ivan, additional, Surguladze, David, additional, Pennello, Anthony L., additional, Persaud, Krishnadatt, additional, Hindi, Sagit, additional, Topper, Michael, additional, Chen, Xinlei, additional, Zhang, Yiwei, additional, Bulaon, Danielle K., additional, Bailey, Tim, additional, Lao, Yanbin, additional, Han, Bing, additional, Torgerson, Stacy, additional, Chin, Darin, additional, Sonyi, Andreas, additional, Haidar, Jaafar N., additional, Novosiadly, Ruslan D., additional, Moxham, Christopher M., additional, Plowman, Gregory D., additional, Ludwig, Dale L., additional, and Kalos, Michael, additional

Published
2020
Full Text
View/download PDF

23. Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity

Author

Kotanides, Helen, primary, Sattler, Rose Marie, additional, Lebron, Maria B., additional, Carpenito, Carmine, additional, Shen, Juqun, additional, Li, Jingxing, additional, Surguladze, David, additional, Haidar, Jaafar N., additional, Burns, Colleen, additional, Shen, Leyi, additional, Inigo, Ivan, additional, Pennello, Anthony L., additional, Forest, Amelie, additional, Chen, Xinlei, additional, Chin, Darin, additional, Sonyi, Andreas, additional, Topper, Michael, additional, Boucher, Lauren, additional, Sharma, Prachi, additional, Zhang, Yiwei, additional, Burtrum, Douglas, additional, Novosiadly, Ruslan D., additional, Ludwig, Dale L., additional, Plowman, Gregory D., additional, and Kalos, Michael, additional

Published
2020
Full Text
View/download PDF

24. The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy

Author

Schaer, David A., primary, Geeganage, Sandaruwan, additional, Amaladas, Nelusha, additional, Lu, Zhao Hai, additional, Rasmussen, Erik R., additional, Sonyi, Andreas, additional, Chin, Darin, additional, Capen, Andrew, additional, Li, Yanxia, additional, Meyer, Catalina M., additional, Jones, Bonita D., additional, Huang, Xiaodong, additional, Luo, Shuang, additional, Carpenito, Carmine, additional, Roth, Kenneth D., additional, Nikolayev, Alexander, additional, Tan, Bo, additional, Brahmachary, Manisha, additional, Chodavarapu, Krishna, additional, Dorsey, Frank C., additional, Manro, Jason R., additional, Doman, Thompson N., additional, Donoho, Gregory P., additional, Surguladze, David, additional, Hall, Gerald E., additional, Kalos, Michael, additional, and Novosiadly, Ruslan D., additional

Published
2019
Full Text
View/download PDF

25. Abstract 3632: Combination of EGFR antibody with PD-1 pathway inhibitors improves anti-tumor efficacy and enhances intra-tumor immune response in preclinical mouse tumor models

Author

Kandaswamy, Veena, primary, Forest, Amelie, additional, Deroose, Marianne, additional, Schaer, David A., additional, Chen, Ting, additional, Liu, Shengwu, additional, Surguladze, David, additional, Yao, Yung-mae, additional, Doman, Thompson, additional, Hall, Gerald, additional, Wong, Kwok-Kin, additional, Kalos, Michael, additional, and Novosiadly, Ruslan D., additional

Published
2018
Full Text
View/download PDF

26. Abstract 2730: Preclinical characterization of the anti-PD-L1 monoclonal antibody LY3300054

Author

Carpenito, Carmine, primary, Li, Yiwen, additional, Wang, George X., additional, Malabunga, Maria S., additional, Haidar, Jaafar N., additional, Forest, Amelie, additional, Murphy, Mary Y., additional, Hall, Gerald E., additional, Wang, Cindy, additional, Shen, Leyi, additional, Sonyi, Andreas, additional, Chin, Darin, additional, Pennello, Anthony L., additional, Inigo, Ivan V., additional, Surguladze, David, additional, Yao, Yung-mae, additional, Burtrum, Douglas, additional, Novosiadly, Ruslan D., additional, Persaud, Kris, additional, Ludwig, Dale L., additional, and Kalos, Michael D., additional

Published
2018
Full Text
View/download PDF

28. Abstract B108: Antitumor efficacy of EGFR antibody necitumumab and dual PI3K/mTOR inhibitor (LY3023414) in preclinical tumor models

Author

Melchior, Maxine A., primary, Guo, Xuemei, additional, Donoho, Gregory P., additional, Iversen, Philip W., additional, Doman, Thompson N., additional, Brahmachary, Manisha, additional, Gong, Xueqian, additional, Hall, Gerald E., additional, Manro, Jason R., additional, Yao, Yung-mae M., additional, Buchanan, Sean, additional, Smeal, Tod, additional, Kalos, Michael D., additional, and Novosiadly, Ruslan D., additional

Published
2018
Full Text
View/download PDF

29. Genomic Characterization of Intrinsic and Acquired Resistance to Cetuximab in Colorectal Cancer Patients

Author

Bray, Steven M, primary, Lee, Jeeyun, additional, Kim, Seung Tae, additional, Young Kim, Sun, additional, Young Hur, Joon, additional, Ebert, Philip J, additional, Calley, John N, additional, Wulur, Isabella H, additional, Gopalappa, Thejaswini, additional, Seong Wong, Swee, additional, Qian, Hui-Rong, additional, Ting, Jason C, additional, Liu, Jiangang, additional, Willard, Melinda D, additional, Novosiadly, Ruslan D, additional, Park, Young Suk, additional, Park, Joon Oh, additional, Lim, Ho Yeong, additional, Ki Kang, Won, additional, Aggarwal, Amit, additional, Cheol Kim, Hee, additional, and Reinhard, Christoph, additional

Published
2018
Full Text
View/download PDF

30. Abstract A160: Combination of necitumumab with second- or third-generation EGFR tyrosine kinase inhibitors downregulates DNA repair mechanisms and induces durable tumor remissions in xenograft NSCLC models with EGFR mutations

Author

Forest, Amelie, primary, Rasmussen, Erik R., additional, Doman, Thompson N., additional, Amatulli, Michael, additional, Bassi, Rajiv, additional, Hall, Gerald E., additional, Manro, Jason R., additional, Brahmachary, Manisha, additional, Surguladze, David, additional, Yao, Yung-mae M., additional, Kalos, Michael D., additional, and Novosiadly, Ruslan D., additional

Published
2018
Full Text
View/download PDF

31. Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations

Author

Yao, Yung-mae M., primary, Donoho, Gregory P., additional, Iversen, Philip W., additional, Zhang, Youyan, additional, Van Horn, Robert D., additional, Forest, Amelie, additional, Novosiadly, Ruslan D., additional, Webster, Yue Wang, additional, Ebert, Philip, additional, Bray, Steven, additional, Ting, Jason C., additional, Aggarwal, Amit, additional, Henry, James R., additional, Tiu, Ramon V., additional, Plowman, Gregory D., additional, and Peng, Sheng-Bin, additional

Published
2017
Full Text
View/download PDF

32. Abstract 5590: Combination of an oncokinase inhibitor merestinib with anti-PD-L1 results in enhanced immune mediated antitumor activity in CT26 murine tumor model

Author

Yan, Sau-Chi Betty, primary, Peek, Victoria L., additional, Stephens, Jennifer R., additional, Um, Um L., additional, Nelusha, Amaladas, additional, Burns, Colleen A., additional, Credille, Kelly M., additional, Doman, Thompson N., additional, Eastman, Scott W., additional, Falcon, Beverly L., additional, Hall, Gerald E., additional, Iversen, Philip W., additional, Konicek, Bruce W., additional, Manro, Jason R., additional, Pappas, Any T., additional, Stewart, Julie A., additional, Topper, Michael B., additional, Wong, Swee-Seong, additional, Kalos, Michael, additional, Novosiadly, Ruslan D., additional, Walgren, Richard A., additional, and Schaer, David, additional

Published
2017
Full Text
View/download PDF

33. Abstract 4104: Intrinsic and acquired resistance to cetuximab in colorectal cancer patients

Author

Bray, Steven M., primary, Lee, Jeeyun, additional, Kim, Seung Tae, additional, Ebert, Philip J., additional, Calley, John N., additional, Wulur, Isabella H., additional, Gopalappa, Thejaswini, additional, Wong, Swee Seong, additional, Qian, Hui-Rong, additional, Ting, Jason C., additional, Liu, Jiangang, additional, Willard, Melinda D., additional, Aggarwal, Amit, additional, Novosiadly, Ruslan D., additional, Kim, Hee-Cheol, additional, and Reinhard, Christoph, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results